Iron therapy for preoperative anaemia
- PMID: 36863388
- DOI: 10.1016/S2352-3026(23)00012-1
Iron therapy for preoperative anaemia
Conflict of interest statement
TR reports university research grants for work in the field of iron deficiency from Vifor Pharma, Pharmacosmos, Pfizer Australia, and BioAge Labs, and consulting fees from BioAge Labs. KH declares no competing interests.
Comment on
-
Ferric carboxymaltose infusion versus oral iron supplementation for preoperative iron deficiency anaemia in patients with colorectal cancer (FIT): a multicentre, open-label, randomised, controlled trial.Lancet Haematol. 2023 Apr;10(4):e250-e260. doi: 10.1016/S2352-3026(22)00402-1. Epub 2023 Feb 27. Lancet Haematol. 2023. PMID: 36863386 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
